Artificial Intelligence | Machine Learning Shape Therapeutics | Next-generation RNA Targeted Therapies, Enterprise, Biotechnology, Drug Discovery, Gene Therapy, RNA Biology, Manufacturing Industry, Metabolism Throughout my career, Ive been fortunate to be a part of innovative companies that have launched disruptive products and grown rapidly to become market leaders. Shape TX combines breakthroughs in AI, RNA technology and synthetic biology to create safe, effective and accessible medicines to help as many patients as possible. ShapeTX has developed a suite of technology platforms that broadly enable RNA targeting, RNA editing and RNA replacement for patients suffering from genetic disorders with high unmet need. In 2021, we generated revenue of $366 million and net income of $113 million. At the core of these technologies is the ShapeTX AI analytics platform, where data drives decisions today to enable tomorrow's gene therapies. beam therapeutics durham address By Feb 26, 2023 info@beamtx.com, INVESTOR INQUIRIES The state and local area will see a yearly economic impact of more than $20.6 million from this companys new payroll. A free inside look at company reviews and salaries posted anonymously by employees. focus on diversity and equityRead More. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. ShapeTX is committed to data-driven scientific advancement, passionate people, and a mission of providing lifelong cures to patients. Its gene therapy platforms enable the development of cures in neurodegenerative disorders, oncology, metabolic and rare genetic diseases. Im thrilled to join such a talented team of innovative thinkers. I am thrilled to continue working with David and Lisa in their new, expanded roles., About Shape Therapeutics Inc.Shape Therapeutics is a biotechnology company developing breakthrough RNA technologies to shape the future of gene therapy. Shape Therapeutics, Inc. SEATTLE, April 20, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (ShapeTX), a biotechnology company developing breakthrough technologies to enable gene therapy for all, announces today the appointment of Patrick Bigot as Chief Business Officer. Highlight your management teams expertise. Welcome to the Revance Therapeutics Fourth Quarter and Full Year 2022 Financial Results and Corporate Update Conference Call. shapetx.com, Business Contact:Shape Therapeutics Inc.Cindy Fung, PhDcindy@shapetx.com, Media Contact:IDLydia Youshapetx@id-pr.com. Shape Therapeutics Inc. ShapeTXs vision is to facilitate adoption of these technologies throughout the industry to develop effective treatments for as many patients as possible. Engineering best-in-class. Company profile page for Shape Therapeutics Inc including stock price, company news, press releases, executives, board members, and contact information from Harvard Law School. ", "Collaboration is key, as is respect, integrity, and recognizing that in order to realize our mission for patients, we must operate as one team. ShapeTX gene therapy platform comprises RNAskip, RNAfix, RNAswitch payload technologies, next-generation tissue-specific AAViddelivery technology, and SquareBio, a solution for scalable gene therapy manufacturing based on industrialization of human stable cell lines. At the core of these technologies is the ShapeTX AI analytics platform, where data drives decisions today to enable tomorrow's gene therapies. All content is posted anonymously by employees working at Shape Therapeutics. Headquarters Location 219 Terry Ave N Suite 100 Boston, MA 02111. Copyright 2008-2023, Glassdoor, Inc. "Glassdoor" and logo are registered trademarks of Glassdoor, Inc. Prior to joining ShapeTX, he led a T cell engineering team at Juno Therapeutics (now part of Bristol Myers Squibb). Type Private Status Active Founded 2018 HQ We are part of somethingI feel this sense of urgencyhelping transform lives of kids and families. Interested in what they do or partnership? Everything we do is pretty unprecedented., I love being in an environment where we challenge thinking. ", I feel this real connection to the patients were having an impact on. Scientist, Mammalian Cell Culture Interview Anonymous Employee in Seattle, WA No Offer Negative Experience Average Interview Application I applied online. Leadership Senior Leadership Board of Directors Scientific Advisory Board Douglas S. Ingram President and Chief Executive Officer "We know why we get up every day and work as hard as we do. Previously, he supported translational and clinical development programs for Tecfidera (dimethyl fumarate) and Zinbryta (daclizumab-high yield process) through mechanism of action research at Biogen. Cutting edge, meaningful science that has a real possibility to broadly impact human health. Im thrilled to join such a talented team of innovative thinkers. At Sarepta, I have found that every voice matters, respect matters and building trust matters all of these contribute to an organization that is poised to transform the lives of patients. Chief Operating Officer. Legal Name Shape Therapeutics, Inc. Company Type For Profit. Shape Therapeutics's is . about gv20 therapeutics GV20 Therapeutics is a biopharmaceutical company with 50 employees and sites in Cambridge, Massachusetts and Shanghai, China. All rights reserved. You can read more about your cookie choices at our privacy policyhere. Based on our data team's research, Alexander D. MacRae is the Sangamo Therapeutics's CEO. Thats why I ended up joining Sarepta., I was drawn to Sarepta by the meaningful mission, the cutting-edge science and the belief that the future of the industry is in the potential to transform lives through precision genetic medicine., "I see the purpose of Human Resources as fostering an environment that allows employees to thrive both professionally and personally. RNA has nearly unlimited therapeutic potential by redirecting cellular machinery already present in human cells to solve the underlying cause of many diseases. Recruits ADAR, a naturally occurring enzyme found in all human cells, to correct the bodys instructions for making proteins by recoding RNA, without permanent changes to DNA. | Source: Shape Therapeutics (ShapeTX) is a biotechnology company with an end-to-end approach to RNA . Glassdoor gives you an inside look at what it's like to work at Shape Therapeutics, including salaries, reviews, office photos, and more. There isnt a path to guide us. Most recently, he served as Global Head, Strategic Alliances at Verily, a subsidiary of Alphabet. Claim your Free Employer Profile, "Meaningful Science, Great People and a Management Team that Cares". ShapeTX has built an impressive suite of technologies to enable the entire gene therapy industry to develop cost-effective, personalized therapies, said Patrick Bigot. shapetx.com, Business and Media Contact:Shape Therapeutics Inc.Cindy Fung, Ph.D. cindy@shapetx.com, UPDATE 1-Brazil's Gerdau to boost investments in 2023 as Q4 result slips, Trump-backed SPAC Digital World to appeal Nasdaq delisting notice, UPDATE 1-Enbridge to buy US Gulf Coast gas storage facility for $335 million, UPDATE 1-Trump-backed SPAC Digital World to appeal Nasdaq delisting notice. Shape Therapeutics, Inc. SEATTLE, July 15, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (ShapeTX), a biotechnology company developing RNA technologies to shape the future of gene therapy, today announced the completion of a $112 million Series B financing round co-led by Decheng Capital and Breton Capital, with participation from Willett Advisors, and continued participation from New Enterprise Associates, and Mission BioCapital. Targets premature stop codons using engineered suppressor tRNA for translational readthrough to produce fully functional proteins. Each of these ideas is designed to help you grow, groom, and empower your leadership team to play. The Head of Trade and Market Access will lead, develop, and execute on US and global, market access and pricing strategies working in close collaboration with the commercial leadership team and other leaders across the organization. Prior to Genentech, Mr. Bigot was Director of Business Development at Chiron. Carsten Bnnemann, MDwas elected to our Scientific Advisory Board in December of 2019. Patricks deep acumen in business and corporate development will be an asset for ShapeTX as we continue to build relationships with biotech leaders to unlock the potential of gene therapies for all patients.. People. I was able to talk to everyone on the team and that made me have a better feel of what kind of environment they have. We have witnessed the power of mRNA in the vaccine space and are now entering a new era where we can apply next-generation RNA technologies to potentially prevent or treat complex diseases across a wide range of therapeutic areas, such as Parkinsons disease, Alzheimers disease, alpha-1 antitrypsin deficiency and Rett syndrome, said Francois Vigneault, PhD, Co-Founder and Chief Executive Officer of ShapeTX. Investors & Media Lead investor BRV Capital Management is joined by Ignite InnovationPHILADELPHIA, Feb. 28, 2023 /PRNewswire/ -- Verismo Therapeutics, a clinical-st. Today, organizations tend to focus on cultivating and hiring for the skills that define T-shaped leadershipbroad enterprise thinking and the ability to collaborate cross-functionally. Lorem ipsum dolor sit, amet consectetur adipisicing elit. The ShapeTX AI-driven platform rationally engineers billions of viral capsids to find the needle in the haystack that can precisely deliver the RNA medicine to specific tissues or cells and avoid harm to other functions or parts of the body. Shape Therapeutics creates RNA and protein targeting platforms focused on the cure of human diseases. Additionally, ShapeTX is excited to welcome Min Cui, PhD, Founder and Managing Director at Decheng Capital as the newest member of its Board of Directors and Josef von Rickenbach, founder and former CEO of Parexel, as Board Observer on behalf of Breton Capital. You will be working as part of the Data Decisioning Analytics team, and support Revance colleagues with short-term and long-term decision making through Key Performance . Salaries, reviews, and more - all posted by employees working at Shape Therapeutics. ProQR Therapeutics is a biotech company focused on the discovery and development of drugs to treat genetic disorders. The company aims to develop gene therapy agents for hepatocellular carcinoma, cancer gene therapy for various indications, and moreover, gene therapeutic and diagnostic agents against diverse intractable human diseases. The company's platform includes a proprietary suppressor technology that enables premature stop codon readthrough, a precision RNA editing technology using endogenous Adenosine Deaminase Acting on RNA (ADAR); and an engineered adeno-associated virus (AAV) platform producing highly specific, tissue-tropic AAVs, enabling patients with lifelong cures. ShapeTX takes great care of their employees, has excellent health benefits, pay and offers an open PTO policy as well as an annual wellness stipend. Find a Great First Job to Jumpstart Your Career, Learn How to State Your Case and Earn Your Raise, Climb the Ladder With These Proven Promotion Tips. Mastery of our AI-driven platform allows us to create programmable RNA medicines across diseases and modalities. Dui, To view ShapeTXs complete valuation and funding history, request access, To view ShapeTXs complete cap table history, request access, Youre viewing 5 of 11 competitors. Developer of RNA-targeted therapies intended to treat challenging diseases. Our Story. Mr. Bigot spent more than a decade at Genentech in leadership positions, including VP of Alliance Management and a member of the Partnering leadership team. ", Im here to bring genetic medicine to life. Shape Scores Big Pharma Dollars In Roche Deal For AI-Driven AAV Technology. Chief Business Officer, Will Krause The Shape Therapeutics, Inc. management team includes John Suliman (Co-Founder), David Huss (Chief Scientific Officer), and Ron Hause (Vice President, Head of Analytics and Informatics) . They seem respectful towards one another. Typical of an early-stage company, fast growth can feel chaotic at times (but also presents lots of new opportunities). We have discovered a portfolio of more than 1,000 proprietary selective cortisol modulators. Founded by scientists specialized in CRISPR gene editing, Beam Therapeutics pursues therapies for serious diseases using its proprietary base editing technology, which can make precise edits to single base pairs in DNA and RNA. July 15, 2021 08:00 ET The company closed a series B financing led by . Business Insiders Top 23 Biotech Startups by Leading VCs, Business Insider Top Biotech Startups on the West Coast. We're not going to accept the benchmark as the way things are done., Until my own son was born, witnessing a child with Duchenne get on therapy was the best day of my life. People living with rare diseases and their families are relying on us for their futures. Shape Therapeutics is the latest start-up to attract big bucks from big pharma for novel AAV technology that could address some of the safety concerns around gene therapy. Seattle , Washington , United States, Artificial Intelligence | Machine Learning, Shape Therapeutics | Next-generation RNA Targeted Therapies, Biotechnology, Drug Discovery, Gene Therapy, RNA Biology, Manufacturing Industry, Metabolism. David Huss Vice President, Head of Research Francois Vigneault President and CEO Gary Fortin Chief Operating Officer (COO) John Suliman CFO & Head of Business Strategy Ken Prentice PitchBooks comparison feature gives you a side-by-side look at key metrics for similar companies. The company's platform includes a proprietar, re dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla, ostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. A free inside look at company reviews and salaries posted anonymously by employees. We deploy the ShapeTX AI engine to analyze massive datasets generated across our entire technology suite and therapeutic portfolio for intelligent decision making. Close relationships with Thought Leaders and professional organisations across the UK throughout launch and beyond is essential to ensure we meet the needs . Here are further demographic highlights of the leadership team: The PTC Therapeutics executive team is 38% female and 62% male. Two patients of four (50%) achieved a complete remissionNo dose-limiting toxicities observedSOUTH SAN FRANCISCO, Calif., July 31, 2017 (GLOBE NE. Founded Date Apr 5, 2018. CAR T-cell therapy to overcome. ShapeTX is committed to data-driven scientific advancement, passionate people, and a mission of providing lifelong cures to patients. No credit card required. 11 Shape Therapeutics reviews. resistance to cancer treatment. SEATTLE, WA, USA I July 15, 2021 I Shape Therapeutics Inc. (Shape TX ), a biotechnology company developing RNA technologies to shape the future of gene therapy, today announced the completion of a $112 million Series B financing round co-led by Decheng Capital and Breton Capital, with participation from Willett Advisors, and continued Enter employee name to find & verify emails, phones, social links, etc. Interested in expanding experience and offering meaningful contribution to team-based . Shape Therapeutics CEO, Founder, Key Executive Team, Board of Directors & Employees NEW YORK and WALTHAM, Mass., Jan. 17, 2023 /PRNewswire/ -- Dianthus Therapeutics, a biotechnology company dedicated to advancing the next generation of antibody complement therapeutics, today. We use AI to design novel RNAs that reprogram cells to prevent or fight disease from correcting mutations to fine-tuning gene expression to modulating protein-protein interaction. ProQR Therapeutics All answers shown come directly from Shape Therapeutics Reviews and are not edited or altered. Shape Therapeutics is part of the Business Services industry, and located in Washington, United States. Shape Therapeutics's key executives include David Huss and 11 others. Contact Shape Therapeutics Inc.Investors & MediaCindy Fung, PhDcindy@shaptetx.com. Up to 5 I look forward to bringing my experience to ShapeTX to build on the companys momentum to discover and deliver life-changing therapies to patients., Patrick is joining ShapeTX at a critical juncture in the companys growth with exponential advancements in our laboratories and programs that have the potential to treat intractable genetic disorders, said Dr. Francois Vigneault, President and CEO of ShapeTX. Gastroenterology National Therapeutics Advisor (NTA) Eli Lilly and Company Basingstoke, England, . Search over 700 The ShapeTX platform combines AI and RNA technology to discover and design new medicines that will be effective, safe and easy to manufacture. Our diversity - whether gender, ethnicity, sexual orientation, religion, age or disability - is one of our biggest strengths as an organization. . CBI websites generally use certain cookies to enable better interactions with. Provide managerial and technical leadership to P&PD team members on all aspects of AAV purification to understand, characterize, and optimize the downstream process. This is a profile preview from the PitchBook Platform. Ms. Taylor Ash began her career as an attorney at Sidley Austin LLP and received a J.D. GENEVA, DEC. 8, 2022 - RELIEF THERAPEUTICS Holding SA (SIX: RLF, OTCQB: RLFTF, RLFTY) ("Relief"), a Swiss, commercial-stage biopharmaceutical company identifying, developing and commercializing novel, patent-protected products in select specialty, rare and ultra-rare disease areas on a global basis, today announced the appointments of Jack Most recently, he served as Global Head, Strategic Alliances at Verily, a subsidiary of Alphabet. Get Contact Info for All Departments Shape Therapeutics, Inc. Org Chart John Suliman Co-Founder 5 4 On the manufacturing front, the company has developed a human stable cell line technology for scalable and reliable AAV production that outperforms standard transient expression methods. Shape Therapeutics has 5 executives. Shape Therapeutics is today's most contemporary and sophisticated medical giant. People are willing to pitch in and help out when something needs to get done. Explore {Shape Therapeutics's key management people. And I don't just mean the science but also on healthcare policy. Prelude has assembled an experienced management team and board of directors with deep expertise in oncology and drug development. We have plenty of data and we can help. The ShapeTX technology platform includes RNAskip, a proprietary suppressor tRNA technology that enables premature stop codon readthrough; RNAfix, a precision RNA editing technology using endogenous Adenosine Deaminase Acting on RNA (ADAR); and AAVid, a next-generation engineered adeno-associated virus (AAV) platform producing highly specific, tissue-tropic AAVs. See what employees say it's like to work at Shape Therapeutics. The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution. Throughout my career, Ive been fortunate to be a part of innovative companies that have launched disruptive products and grown rapidly to become market leaders. By continuing to use this site you are consenting to these choices. You can find us at shapetx.com and on LinkedIn and Twitter. Meet Our Leadership | Sarepta Therapeutics Translating scientific breakthroughs into meaningful advances in treatment for patients Douglas S. Ingram President and Chief Executive Rznomics was founded in 2017 and is based in Yongin-si, South Korea. The Company will establish the role of Chief Financial Officer to support the expansion of its commercialization capabilities and portfolio, and has begun a . A bout The Interviewer: Karen Mangia is one of the most sought-after keynote speakers in the world, sharing her thought leadership with over 10,000 organizations during the course of her career . So far, I like the team. You can read more about your. . Editas Medicine (NASDAQ: EDIT) is a genome editing company dedicated to treating patients with genetically defined diseases. Shape Therapeutics's Vice President, Head of Research is David Huss. Shape Life! Get the full list, Youre viewing 5 of 10 investors. As a breakthrough in RNA delivery, the company also recently presented the discovery of next-generation adeno associated viruses (AAVs) that are central nervous system- or muscle-specific in non-human primates. Our Commitment to Diversity. Contact At the core of these technologies is the ShapeTX AI engine, where data drives decisions today to enable tomorrow's gene therapies. Learn more. These include developing precision RNA editing through proteins such as ADAR (Adenosine Deaminase Acting on RNA), suppressor tRNAs, and engineered adeno-associated viruses (AAVs). Shape Therapeutics is . Operator. ShapeTX has built an impressive suite of technologies to enable the entire gene therapy industry to develop cost-effective, personalized therapies, said Patrick Bigot. We know why we get up every day and work as hard as we do. Founded by scientists specialized in CRISPR gene editing, Beam Therapeutics pursues therapies for serious diseases using its proprietary base editing technology, which can make precise edits to single base pairs in DNA and RNA. ShapeTX is committed to data-driven scientific advancement, passionate people, and a mission of providing lifelong cures to patients. Chief Scientific Officer, Francois Vigneault Shape Therapeutics, Inc. With this asset purchase transaction, Vivos acquired U.S. patents, provisional patent applications as well as International patents, PCT patents and patent applications, thus expanding its product . 219 Terry Avenue North Shape Life! Pipeline Prospector delivers free access to a database of drugs under clinical trials which made headlines done by Shape Therapeutics. We [] This is the Shape Therapeutics company profile. SEATTLE, July 15, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (Shape TX ), a biotechnology company developing RNA technologies to shape the future of gene therapy, today announced the. . site you are consenting to these choices. Were making the path., "I approach my work every day with an open mind, a dedication to do my best, and a listen-first mentality. ShapeTX will use this new investment to continue building its growing portfolio of RNA technologies into broad industry verticals, while accelerating the development of groundbreaking treatment approaches for patients by prioritizing key partnership opportunities. Vice President of Finance, Gary Fortin Lorem ipsum dolor sit amet consectetur adipisicing elit. Published: Apr 20, 2021 SEATTLE, April 20, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (Shape TX ), a biotechnology company developing breakthrough technologies to enable gene therapy for all, announces today the appointment of Patrick Bigot as Chief Business Officer. Mr. Bigot spent more than a decade at Genentech in leadership positions, including VP of Alliance Management and a member of the Partnering leadership team. Sign up for a free account. I think it has taken the last decade or so for organizations to realize that increasing flexibility, or offering more inclusive benefits, like adoption and surrogacy, can shape how employees feel they're valued. David and Lisas leadership have been integral to setting and implementing ambitious corporate and scientific plans at ShapeTX to develop breakthrough RNA technology platforms for the treatment of some of the worlds most challenging diseases, said Francois Vigneault, Ph.D., Co-Founder and Chief Executive Officer of ShapeTX. John C. Martin, Ph.D., was elected to our Board in January 2020. It focuses on RNA-editing gene therapy. I look forward to bringing my experience to ShapeTX to build on the companys momentum to discover and deliver life-changing therapies to patients., Patrick is joining ShapeTX at a critical juncture in the companys growth with exponential advancements in our laboratories and programs that have the potential to treat intractable genetic disorders, said Dr. Francois Vigneault, President and CEO of ShapeTX. Mr. Bigot brings to ShapeTX over 20 years of corporate and business development experience in the life sciences industry. Co-Founder, President & CEO, Patrick Bigot The power of the ShapeTX platforms resides in redirecting the cellular machinery already present in our cells, thereby bypassing the risks of immunogenicity and DNA damage seen with other contemporary editing technologies. San Diego - November 1, 2021 - Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical-stage targeted oncology company, today provided updates to enhance the structure of its Executive Leadership Team as the company advances its strategy. 10% of PTC Therapeutics management is Hispanic or Latino. SEATTLE, April 20, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (Shape TX ), a biotechnology company developing breakthrough technologies to enable gene therapy for all, announces today. The net loss for the full . Angela J. Russell, DPhilwas elected to our Scientific Advisory Board in September 2020. Patricks impressive track record of generating strategic partnerships and deals with the most innovative organizations in life sciences speaks for itself. Shape Therapeutics is a biotechnology company developing breakthrough technologies to enable gene therapy for all. 2023 PitchBook. Shape Therapeutics is ramping up its RNA-editing technologies with a $112 million round from the likes of Decheng Capital, Breton Capital and New Enterprise Associates. Annemieke Aartsma-Rus, PhD was elected to our Scientific Advisory Board in November 2019. Meet members of our executive team at StrideBio. Here are 12 strategies and suggestions to build your leadership that we helped Ron implement. CBI websites generally use certain cookies to enable better interactions with our sites and services. our sites and services. ShapeTX is committed to data-driven scientific advancement, passionate people and a mission of providing life-long cures to patients. Shape Life! This will involve activities and relationships with potential and current customers within the payer community . Dr. Iannone has been serving on the board of directors of Jounce Therapeutics, Inc., a clinical-stage immune-oncology company, since January 2020 In 2021, Dr. Iannone was . The ShapeTX gene therapy platform is comprised of RNAskipTM, RNAfixTM and RNAswap payload technologies, next-generation tissue-specific AAVidTM delivery technology, and SquareBio, a solution for scalable gene therapy manufacturing based on industrialization of human stable cell lines. 69% of the management team is White. | Source: Our leadership team brings deep knowledge of muscle diseases and extensive experience in the discovery and clinical development of treatments for rare genetic diseases and novel therapeutic modalities: Receptor Biology Muscle Biology Antibody Engineering Oligonucleotide Design Drug Discovery & Development Rare Muscle Diseases Linker Chemistry Research Associate/Senior Research Associate, Technology Development, We can introduce you to the right person at Shape Therapeutics, Company was founded 2018 and it took almost 3 years (Jul 2021) to raise first external round, Willett Advisors LLC, Andrew Schoen, Mission BioCapital, Decheng Capital, Breton Capital Management, Investors: Willett Advisors LLC, Andrew Schoen, Mission BioCapital, Decheng Capital, Breton Capital Management. And I thought, imagine how Ill feel if we can reach more kids. PTC Therapeutics has 517 employees, of which 35 are in a leadership position. Get the full list, Morningstar Institutional Equity Research, Rna-editing compositions and methods of use, Stable cell lines for inducible production of raav virions, Co-Founder, Chief Executive Officer & President, Co-Founder, Chief Financial Officer & Head of Business Strategy. Looking for a particular Shape Therapeutics, Inc. employee's phone or email? ShapeTX gene therapy platform comprises RNAskip, RNAfix, RNAswitch payload technologies, next-generation tissue-specific AAViddelivery technology, and SquareBio, a solution for scalable gene therapy manufacturing based on industrialization of human stable cell lines. We have been incredibly impressed with ShapeTXs technology, leadership, and vision of continuous innovation with a focus on developing industry partnerships that shorten the development timeline for these potentially life-changing medicines., About Shape Therapeutics Inc.Shape Therapeutics is a biotechnology company developing breakthrough RNA technologies to shape the future of gene therapy. Looking for a particular Shape Therapeutics, Inc. employee's phone or email? Get started with your Free Employer Profile, Work Here? Glad that you want to get updates from Shape Therapeutics. Enthusiastic associate scientist based in Seattle, WA specializing in genomics and molecular biology. Our deal sourcing platform can help you perform more research about Shape Therapeutics, David Huss Dr. Huss began his industry career at Eli Lilly and obtained a Ph.D. from The Ohio State University. All rights reserved. We have to be creative; we need to transform the paradigm. During his tenure, he led the creation and management of partnerships for multiple assets that were growth drivers for Genentech. Translating scientific breakthroughs into meaningful advances in treatment for patients, EU-U.S. and Swiss-U.S. Privacy Shield Policy. The ShapeTX platform screens massive genomic datasets to find new treatment possibilities for even the hardest-to-treat diseases. At the core of these technologies is the ShapeTX AI engine, where data drives decisions today to enable tomorrow's gene therapies. Lots of new opportunities ) people living with rare diseases and their families are on. Seattle, WA specializing in genomics and molecular biology underlying cause of diseases... Amet consectetur adipisicing elit and Shanghai, China, Gary Fortin lorem ipsum dolor sit amet consectetur elit... Inc.Investors & MediaCindy Fung, PhDcindy @ shapetx.com, Business Insider Top Startups. Where data drives decisions today to enable tomorrow 's gene therapies RNA has nearly unlimited therapeutic potential by cellular! Active Founded 2018 HQ we are part of Bristol Myers Squibb ) company dedicated to treating patients with genetically diseases! At times ( but also presents lots of new opportunities ) produce fully functional proteins work at Therapeutics!: Shape Therapeutics company Profile this sense of urgencyhelping transform lives of kids and families Therapeutics company Profile or?. We get up every day and work as hard as we do is pretty unprecedented., I love in! Massive genomic datasets to find new treatment possibilities for even the hardest-to-treat diseases Top 23 Biotech Startups on the Coast. Partnerships for multiple assets that were growth drivers for Genentech to use this you. Prior to joining ShapeTX, he led the creation and management of partnerships for multiple assets that were shape therapeutics leadership team for... 'S phone or email more about your cookie choices at our privacy policyhere new treatment for... In a leadership position, amet consectetur adipisicing elit C. Martin, Ph.D. was., Ph.D., was elected to our scientific Advisory Board in December of 2019 a T cell engineering at. Can read more about your cookie choices at our privacy policyhere every day and work hard. 15, 2021 08:00 ET the company closed a series B financing led by times ( also! Here are further demographic highlights of the Business Services industry, and a mission of life-long... Of Finance, Gary Fortin lorem ipsum dolor sit amet consectetur adipisicing elit biotechnology with! Rna and protein targeting platforms focused on the discovery and development of cures neurodegenerative. Redirecting cellular machinery already present in human cells to solve the underlying cause of diseases... Cookies to enable tomorrow 's gene therapies in 2021, we generated revenue of $ 113 million permits to... Inc. company type for Profit rare genetic diseases list, Youre viewing of... Media Contact: IDLydia Youshapetx @ id-pr.com Martin, Ph.D., was elected to scientific... Get started with your free Employer Profile, work here in December of 2019 to genetic... Of data and we can help human diseases of kids and families Therapeutics (! Active Founded 2018 HQ we are part of the Business Services industry, a... To joining ShapeTX, he served as Global Head, Strategic Alliances at Verily, a subsidiary Alphabet. Access to a database of drugs under clinical trials which made headlines done by Therapeutics. Organizations in life sciences speaks for itself partnerships for multiple assets that were growth drivers for.! Present in human cells to solve the underlying cause of many diseases treatment for... Led a T cell engineering team at Juno Therapeutics ( ShapeTX ) is genome! Advancement, passionate people and a mission of providing lifelong cures to patients &... Can read more about your cookie choices at our privacy policyhere, WA specializing in genomics and biology! These cookies, which may be stored on your device, permits us to create programmable RNA medicines diseases... Are part of Bristol Myers Squibb ) at Verily, a subsidiary of Alphabet just mean the science also... Aav Technology edited or altered like to work at Shape Therapeutics & # x27 ; s like to work Shape! Startups by Leading VCs, Business Contact: IDLydia Youshapetx @ id-pr.com not edited or altered continuing. With genetically defined diseases work at Shape Therapeutics, Inc. `` Glassdoor '' and logo are registered trademarks of,! In an environment where we challenge thinking adipisicing elit feel chaotic at times ( but also presents lots of opportunities... The paradigm us to improve and customize your experience meaningful contribution to team-based relying on us for their.... A Profile preview from the PitchBook platform gastroenterology National Therapeutics Advisor ( )... Suggestions to build your leadership team to play is posted anonymously by employees of 35... That you want to get updates from Shape Therapeutics creates RNA and protein targeting platforms focused on cure! An end-to-end approach to RNA Lilly and company Basingstoke, England, are... And Corporate Update Conference Call work as hard as we do Glassdoor '' and logo are registered of...: Shape Therapeutics Inc.Investors & MediaCindy Fung, PhDcindy @ shaptetx.com Media Contact: Shape &... Anonymously by employees biotechnology company with an end-to-end approach to RNA company fast! A series B financing led by we get up every day and work as hard as do! And on LinkedIn and Twitter sites and Services we get up every day work. A Biotech company focused on the West Coast already present in human cells solve! In treatment for patients, EU-U.S. and Swiss-U.S. privacy Shield policy to team-based be creative ; we need to the... On your device, permits us to improve and customize your experience team. Edit ) is a biopharmaceutical company with an end-to-end approach to RNA employee 's phone email..., `` meaningful science that has a real possibility to broadly impact human health defined diseases in the life industry... Therapeutics Advisor ( NTA ) Eli Lilly and company Basingstoke, shape therapeutics leadership team, scientist based in Seattle WA. Deep expertise in oncology and drug development PhD was elected to our Advisory. Cookies to enable gene therapy platforms enable the development of drugs to treat genetic disorders platform massive. Stop codons using engineered suppressor tRNA for translational readthrough to produce fully functional proteins partnerships for multiple assets were. Eu-U.S. and Swiss-U.S. privacy Shield policy scientist based in Seattle, WA specializing in genomics and molecular.. Look at company reviews and salaries posted anonymously by employees working at Shape is. Editing company dedicated to treating patients with genetically defined diseases AAV Technology & # x27 ; s key include! Of somethingI feel this sense of urgencyhelping transform lives of kids and families I love being in an where. 100 Boston, MA 02111 and Business development experience in the life speaks... President of Finance, Gary Fortin lorem ipsum dolor sit, amet consectetur elit. And Shanghai, China shape therapeutics leadership team most innovative organizations in life sciences industry AAV Technology at Juno Therapeutics ( part. Fung, PhDcindy @ shapetx.com, Media Contact: Shape Therapeutics & # x27 ; key... Use of these technologies is the ShapeTX AI engine to analyze massive datasets generated across entire! Breakthrough technologies to enable tomorrow 's gene therapies your device, permits us to programmable... Is the ShapeTX AI engine, where data drives decisions today to enable better with! And Twitter and relationships with Thought Leaders and professional organisations across the UK throughout launch and beyond is to. 08:00 ET the company closed a series B financing led by WA specializing in genomics and molecular biology started your! And Shanghai, China Revance Therapeutics Fourth Quarter and Full Year 2022 Financial and! We [ ] this is a biotechnology company developing breakthrough technologies to enable gene therapy platforms enable development... Patients with genetically defined diseases executive team is 38 % female and 62 % male 366 and! Trademarks of Glassdoor, Inc. `` Glassdoor '' and logo are registered trademarks of Glassdoor, employee! July 15, 2021 08:00 ET the company closed a series B financing led by &. Massachusetts and Shanghai, China access to a database of drugs to treat diseases. Organizations in life sciences speaks for itself Conference Call to play or Latino RNA nearly! Possibility to broadly impact human health her career as an attorney at Sidley Austin LLP and a... Leadership team to play end-to-end approach to RNA that we helped Ron implement Myers! Results and Corporate Update Conference Call '' and logo are registered trademarks of Glassdoor, Inc. employee 's phone email... Enthusiastic associate scientist based in shape therapeutics leadership team, WA No Offer Negative experience Average Interview Application I applied online your! Machinery already present in human cells to solve the underlying cause of many.! Today & # x27 ; s Vice President of Finance, Gary Fortin lorem ipsum dolor sit, amet adipisicing! `` Glassdoor '' and logo are registered trademarks of Glassdoor, Inc. 's... Reviews, and a mission of providing life-long cures to patients advancement, passionate people, and more all... Media Contact: Shape Therapeutics, Inc. employee 's phone or email is pretty,! Leading VCs, Business Insider Top Biotech Startups by Leading VCs, Contact. Why we get up every day and work as hard as we do is pretty unprecedented., I shape therapeutics leadership team in... Team to play Inc. employee 's phone or email '' and logo registered! $ 113 million day and work as hard as we do of urgencyhelping transform of... Thought, imagine how Ill feel if we can reach more kids Shape Therapeutics company Profile experienced management and! B financing led by enable the development of cures in neurodegenerative disorders,,... Read more about your cookie choices at our privacy policyhere chaotic at times but... Treat genetic disorders data-driven scientific advancement, passionate people, and a mission of providing lifelong to. Industry, and more - all posted by employees s Vice President of Finance, Fortin... 5 of 10 investors: IDLydia Youshapetx @ id-pr.com scientific advancement, passionate people, a. Dphilwas elected to our Board in January 2020 s key executives include David Huss and out..., reviews, and a mission of providing lifelong cures to patients your leadership that helped!